Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
361 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//POLYOMAVIRUS | 35836 |
818 | 2 | ONCOLYTIC VIRUS//GENE THERAPY//HUMAN GENE THERAPY | 12130 |
957 | 1 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS | 2970 |
3303 | 1 | RETROVIRAL VECTOR//HUMAN GENE THERAPY//SELECTIVE AMPLIFIER GENE | 2048 |
3933 | 1 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE | 1914 |
3956 | 1 | LENTIVIRAL VECTOR//LENTIVIRUS//EXPT HEMATOL | 1909 |
14333 | 1 | MOL MED GENE THER Y UNIT//HERPES SIMPLEX VIRUS VECTOR//W ROXBURY VA HOSP | 808 |
15515 | 1 | TET SYSTEM//TET ON SYSTEM//TET ON | 735 |
15875 | 1 | HSV1 TK//FIAU//F 18FHBG | 713 |
19853 | 1 | RAD P53//RECOMBINANT ADENOVIRUS P53//P53 GENE THERAPY | 509 |
29662 | 1 | GENETIC RADIOTHERAPY//TNFERADE//CARG ELEMENTS | 199 |
31537 | 1 | THER EUT IMMUNOMOL//CLIN BIOMONITORING//ESA 7087 | 165 |
31824 | 1 | 2A PEPTIDE//FMDV 2A//2A | 160 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | authKW | 708073 | 3% | 73% | 373 |
2 | GENE THERAPY | authKW | 688014 | 16% | 13% | 1979 |
3 | HUMAN GENE THERAPY | journal | 466965 | 6% | 23% | 780 |
4 | CANCER GENE THERAPY | journal | 364252 | 4% | 27% | 524 |
5 | LENTIVIRAL VECTOR | authKW | 314830 | 3% | 35% | 349 |
6 | VIROTHERAPY | authKW | 297606 | 1% | 67% | 171 |
7 | MOLECULAR THERAPY | journal | 291430 | 5% | 18% | 643 |
8 | RETROVIRAL VECTOR | authKW | 259999 | 2% | 34% | 293 |
9 | ONCOLYTIC ADENOVIRUS | authKW | 250051 | 1% | 60% | 161 |
10 | SUICIDE GENE THERAPY | authKW | 215514 | 1% | 62% | 133 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 91667 | 33% | 1% | 3995 |
2 | Biotechnology & Applied Microbiology | 67162 | 32% | 1% | 3878 |
3 | Genetics & Heredity | 55903 | 29% | 1% | 3483 |
4 | Oncology | 22567 | 24% | 0% | 2878 |
5 | Virology | 9266 | 7% | 0% | 858 |
6 | Hematology | 5150 | 7% | 0% | 849 |
7 | Biochemistry & Molecular Biology | 3422 | 18% | 0% | 2170 |
8 | Cell Biology | 1575 | 8% | 0% | 954 |
9 | Cell & Tissue Engineering | 873 | 1% | 0% | 108 |
10 | Biochemical Research Methods | 649 | 3% | 0% | 414 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC GENE THER Y GRP | 137744 | 1% | 58% | 91 |
2 | HUMAN GENE THER Y | 84909 | 1% | 22% | 149 |
3 | SAN DIEGO SCI | 81322 | 0% | 61% | 51 |
4 | EXPT HEMATOL | 63898 | 2% | 12% | 205 |
5 | MOL MED GENE THER Y UNIT | 61446 | 0% | 72% | 33 |
6 | W ROXBURY VA HOSP | 39487 | 0% | 89% | 17 |
7 | GENE THER Y | 38010 | 2% | 7% | 202 |
8 | MOL NEUROONCOL S | 37481 | 0% | 76% | 19 |
9 | XINYUAN MED BIOTECHNOL | 36583 | 0% | 34% | 42 |
10 | DARDINGER NEUROONCOL NEUROSCI | 35916 | 0% | 46% | 30 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 466965 | 6% | 23% | 780 |
2 | CANCER GENE THERAPY | 364252 | 4% | 27% | 524 |
3 | GENE THERAPY | 323519 | 6% | 18% | 703 |
4 | MOLECULAR THERAPY | 291430 | 5% | 18% | 643 |
5 | JOURNAL OF GENE MEDICINE | 85554 | 2% | 15% | 218 |
6 | MOLECULAR THERAPY-ONCOLYTICS | 48034 | 0% | 51% | 36 |
7 | CURRENT GENE THERAPY | 44909 | 1% | 17% | 100 |
8 | HUMAN GENE THERAPY METHODS | 22888 | 0% | 22% | 40 |
9 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 22354 | 1% | 10% | 87 |
10 | MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 13222 | 0% | 15% | 34 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | 708073 | 3% | 73% | 373 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
2 | GENE THERAPY | 688014 | 16% | 13% | 1979 | Search GENE+THERAPY | Search GENE+THERAPY |
3 | LENTIVIRAL VECTOR | 314830 | 3% | 35% | 349 | Search LENTIVIRAL+VECTOR | Search LENTIVIRAL+VECTOR |
4 | VIROTHERAPY | 297606 | 1% | 67% | 171 | Search VIROTHERAPY | Search VIROTHERAPY |
5 | RETROVIRAL VECTOR | 259999 | 2% | 34% | 293 | Search RETROVIRAL+VECTOR | Search RETROVIRAL+VECTOR |
6 | ONCOLYTIC ADENOVIRUS | 250051 | 1% | 60% | 161 | Search ONCOLYTIC+ADENOVIRUS | Search ONCOLYTIC+ADENOVIRUS |
7 | SUICIDE GENE THERAPY | 215514 | 1% | 62% | 133 | Search SUICIDE+GENE+THERAPY | Search SUICIDE+GENE+THERAPY |
8 | SUICIDE GENE | 205988 | 1% | 52% | 152 | Search SUICIDE+GENE | Search SUICIDE+GENE |
9 | CYTOSINE DEAMINASE | 203032 | 1% | 60% | 130 | Search CYTOSINE+DEAMINASE | Search CYTOSINE+DEAMINASE |
10 | ADENOVIRUS | 189681 | 5% | 12% | 614 | Search ADENOVIRUS | Search ADENOVIRUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |